Company news: Amgen (AMGN) quarterly earnings beat analysts’ expectations

Amgen (AMGN) reported Q1 FY2024 earnings of $3.96 per share (versus $3.98 per share in Q1 FY2023), beating analysts’ consensus estimate of $3.88 per share.

The company’s quarterly revenues amounted to $7.447 bln (+22.0% y/y), slightly missing analysts’ consensus estimate of $7.452 bln.

The company also issued in-line guidance for FY2024, seeing EPS of $19.00-20.20 versus analysts’ consensus estimate of $19.47 and revenues of $32.5-$33.8 bln versus analysts’ consensus estimate of $32.96 bln.

AMGN rose to $316.00 (+13.51%) in pre-market trading.